{"id":"https://openalex.org/W2058090754","doi":"https://doi.org/10.1016/s1083-8791(00)70041-3","title":"An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD","display_name":"An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD","publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W2058090754","doi":"https://doi.org/10.1016/s1083-8791(00)70041-3","mag":"2058090754","pmid":"https://pubmed.ncbi.nlm.nih.gov/10816026"},"language":"en","primary_location":{"id":"doi:10.1016/s1083-8791(00)70041-3","doi":"https://doi.org/10.1016/s1083-8791(00)70041-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","pdf_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111591999","display_name":"M.J. Petrus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Petrus","raw_affiliation_strings":["Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007653074","display_name":"Jonathan F. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["MY","US"],"is_corresponding":false,"raw_author_name":"Jonathan F. Williams","raw_affiliation_strings":["Medical Oncology Branch , National Cancer Institute , and","Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Branch , National Cancer Institute , and","institution_ids":["https://openalex.org/I4210134348","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014572331","display_name":"Michael Eckhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Eckhaus","raw_affiliation_strings":["National Institutes of Health , 9000 Rockville Pike , Building 10 , Room 12N226 , Bethesda , MD 20892 ;","The National Center for Research Resources , National Institutes of Health , Bethesda , Mary l","Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health , 9000 Rockville Pike , Building 10 , Room 12N226 , Bethesda , MD 20892 ;","institution_ids":["https://openalex.org/I1299303238"]},{"raw_affiliation_string":"The National Center for Research Resources , National Institutes of Health , Bethesda , Mary l","institution_ids":["https://openalex.org/I1299303238"]},{"raw_affiliation_string":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066218992","display_name":"Ronald E. Gress","orcid":"https://orcid.org/0000-0001-8259-5332","observed_orcids":["https://orcid.org/0000-0001-8259-5332"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["MY","US"],"is_corresponding":false,"raw_author_name":"Ronald E. Gress","raw_affiliation_strings":["Medical Oncology Branch , National Cancer Institute , and","Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Branch , National Cancer Institute , and","institution_ids":["https://openalex.org/I4210134348","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074220802","display_name":"Daniel H. Fowler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134348","display_name":"National Cancer Institute","ror":"https://ror.org/044ybef51","country_code":"MY","type":"government","lineage":["https://openalex.org/I105292261","https://openalex.org/I4210134348"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["MY","US"],"is_corresponding":false,"raw_author_name":"Daniel H. Fowler","raw_affiliation_strings":["Medical Oncology Branch , National Cancer Institute , and","Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Branch , National Cancer Institute , and","institution_ids":["https://openalex.org/I4210134348","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":1.9915,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.85891763,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"6","issue":"2","first_page":"182","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12900","display_name":"Organ and Tissue Transplantation Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":1.0},{"id":"https://openalex.org/keywords/graft-rejection","display_name":"graft rejection","score":0.5590000152587891},{"id":"https://openalex.org/keywords/mhc-mismatch","display_name":"MHC mismatch","score":0.7490000128746033},{"id":"https://openalex.org/keywords/bone-marrow-transplantation","display_name":"bone marrow transplantation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8389999866485596},{"id":"https://openalex.org/keywords/donor-chimerism","display_name":"donor chimerism","score":0.7279999852180481},{"id":"https://openalex.org/keywords/t-cell-depletion","display_name":"T cell depletion","score":0.5299999713897705},{"id":"https://openalex.org/keywords/total-body-irradiation","display_name":"total body irradiation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/nonmyeloablative-conditioning","display_name":"nonmyeloablative conditioning","score":0.7490000128746033},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.5519999861717224},{"id":"https://openalex.org/keywords/myeloid-cell-depletion","display_name":"myeloid cell depletion","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.7977765798568726},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7862634062767029},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.768082857131958},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7385499477386475},{"id":"https://openalex.org/C2778880498","wikidata":"https://www.wikidata.org/wiki/Q1986672","display_name":"Total body irradiation","level":4,"score":0.6454547643661499},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5678792595863342},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.562161922454834},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.525246798992157},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4297243058681488},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4238382875919342},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.38649773597717285},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3714035451412201}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D006648","descriptor_name":"Histocompatibility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014916","descriptor_name":"Whole-Body Irradiation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D016026","descriptor_name":"Bone Marrow Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016026","descriptor_name":"Bone Marrow Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018183","descriptor_name":"Transplantation Chimera","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D019070","descriptor_name":"Cell Lineage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s1083-8791(00)70041-3","doi":"https://doi.org/10.1016/s1083-8791(00)70041-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","pdf_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},{"id":"pmid:10816026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10816026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1016/s1083-8791(00)70041-3","doi":"https://doi.org/10.1016/s1083-8791(00)70041-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","pdf_url":"https://doi.org/10.1016/s1083-8791(00)70041-3","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7300000190734863}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2058090754.pdf","grobid_xml":"https://content.openalex.org/works/W2058090754.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2154260","https://openalex.org/W24911164","https://openalex.org/W1508187469","https://openalex.org/W1564309137","https://openalex.org/W1831821249","https://openalex.org/W1853568500","https://openalex.org/W1883328448","https://openalex.org/W1977557283","https://openalex.org/W2024190599","https://openalex.org/W2039887904","https://openalex.org/W2052605694","https://openalex.org/W2094292853","https://openalex.org/W2101912624","https://openalex.org/W2120428769","https://openalex.org/W2126796352","https://openalex.org/W2128070857","https://openalex.org/W2150841203","https://openalex.org/W2287087682","https://openalex.org/W2408826253","https://openalex.org/W2412912501","https://openalex.org/W4241060011"],"related_works":["https://openalex.org/W2020725971","https://openalex.org/W2015251625","https://openalex.org/W2570427855","https://openalex.org/W1986782001","https://openalex.org/W2071104756","https://openalex.org/W2032965190","https://openalex.org/W2150841203","https://openalex.org/W2208607838","https://openalex.org/W2328913417","https://openalex.org/W2130791161"],"abstract_inverted_index":{"The":[0,193],"prevention":[1],"of":[2,8,24,50,64,93,112,115,140,157,175,196,227,238,272,308],"graft":[3],"rejection":[4,44,216,246,285,306],"in":[5,256],"the":[6,21,224,267],"setting":[7],"nonmyeloablative":[9],"transplant":[10],"approaches":[11],"might":[12,34],"be":[13],"mediated":[14],"by":[15,20],"chemotherapy-induced":[16],"host":[17,31,47,81,94,96,136,206,278],"immunoablation":[18,32],"and":[19,67,173,242,259],"graft-promoting":[22],"effects":[23],"graft-versus-host":[25],"disease":[26],"(GVHD).":[27],"To":[28],"evaluate":[29],"whether":[30,80],"alone":[33],"allow":[35],"for":[36,150,167,185],"alloengraftment,":[37],"we":[38],"developed":[39],"an":[40,109],"F1-into-parent":[41],"murine":[42],"marrow":[43,215,245,284,305],"model":[45],"using":[46],"preparative":[48,71,102,299],"regimens":[49,133,300],"lethal":[51,116,239],"total":[52],"body":[53],"irradiation":[54,59],"(TBI;":[55],"950":[56],"cGy),":[57,61],"sublethal":[58],"(600":[60],"or":[62,187,269],"combinations":[63],"fludarabine":[65],"(Flu)":[66],"cyclophosphamide":[68],"(Cy).":[69],"A":[70],"regimen":[72,103,195,226,271],"selectivity":[73],"index":[74],"(SI)":[75],"was":[76,254,260],"calculated":[77],"to":[78,87,123],"determine":[79],"lymphocytes":[82],"were":[83,107],"preferentially":[84,134],"depleted":[85,135,277],"relative":[86,122],"myeloid":[88,120],"cells":[89,99,121,125,258],"(SI":[90,126,153,170,190],"=":[91,127,154,171,191,220,250,289],"number":[92],"myeloid/number":[95],"T":[97,124,137,207,279],"lymphoid":[98,257],"remaining":[100],"after":[101],"administration).":[104],"Saline-treated":[105],"recipients":[106,139,156,174,241],"assigned":[108],"SI":[110],"value":[111],"1.0.":[113],"Recipients":[114],"TBI":[117,240],"had":[118],"reduced":[119,233],"0.6).":[128],"In":[129,222],"contrast,":[130,223],"all":[131],"Flu/Cy":[132,197,228],"cells:":[138],"Flu":[141,158,176],"(100":[142,159,163,177,229],"mg/kg":[143,147,160,164,178,182,199,230],"per":[144,148,161,165,179,183,200,231],"day)/Cy":[145,162,180],"(50":[146,181,198],"day)":[149,166,184,201,232],"10":[151,168],"days":[152,169,189],"28.1);":[155],"64.1);":[172],"19":[186],"27":[188],"74.6).":[192],"10-day":[194,225],"did":[202,211],"not":[203],"severely":[204],"reduce":[205],"cell":[208],"numbers,":[209],"nor":[210],"it":[212],"prevent":[213,302],"F1":[214,244,283],"(<1%":[217],"chimerism,":[218,248,287],"n":[219,249,288],"14).":[221],"T-cell":[234],"numbers":[235],"below":[236],"that":[237,295],"prevented":[243,282],"(11.4%":[247],"15);":[251],"donor":[252],"chimerism":[253],"predominant":[255],"stable":[261],"through":[262],"day":[263],"240":[264],"post-BMT.":[265],"Additionally,":[266],"19-":[268],"27-day":[270],"Flu/Cy,":[273],"which":[274],"most":[275],"selectively":[276],"cells,":[280],"also":[281],"(6.3%":[286],"15).":[290],"These":[291],"results":[292],"therefore":[293],"demonstrate":[294],"optimized":[296],"Flu-containing,":[297],"immunoablative":[298],"can":[301],"fully":[303],"MHC-disparate":[304],"independent":[307],"GVHD.":[309]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}